Device
the New Tissue Containment System
Total Trials
3
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Active Trials
0(0%)
Phase Distribution
Ph not_applicable
3
100%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Other(3)
Detailed Status
unknown3
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
N/A
Most Advanced
N/A
Trials by Phase
N/A3 (100.0%)
Trials by Status
unknown3100%
Recent Activity
0 active trials
Showing 3 of 3
unknownnot_applicable
Safety and Efficacy of Using the New Tissue Containment System During Laparoscopic Myomectomy Morcellation
NCT04392674
unknownnot_applicable
Safety, Effectiveness and Operability of Using the New Tissue Containment System During Laparoscopic Ovarian Cystectomy
NCT04406597
unknownnot_applicable
Safety, Efficacy and Operability of Using the New Tissue Containment System During Laprascopic Hysterectomy
NCT04423172
Clinical Trials (3)
Showing 3 of 3 trials
NCT04392674Not Applicable
Safety and Efficacy of Using the New Tissue Containment System During Laparoscopic Myomectomy Morcellation
NCT04406597Not Applicable
Safety, Effectiveness and Operability of Using the New Tissue Containment System During Laparoscopic Ovarian Cystectomy
NCT04423172Not Applicable
Safety, Efficacy and Operability of Using the New Tissue Containment System During Laprascopic Hysterectomy
All 3 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 3